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Abstract
Purpose The aim was to test the impact of body mass
index (BMI) and gender on infectious complications after
polytrauma.
Methods A total of 651 patients were included in this
retrospective study, with an Injury Severity Score
(ISS) C16 and age C16 years. The sample was subdivided
into three groups: BMI \25 kg/m2, BMI 25–30 kg/m2, and
BMI [30 kg/m2, and a female and a male group. Infectious
complications were observed for 31 days after admission.
Data are given as mean ± standard errors of the means.
Analysis of variance, Kruskal–Wallis test, v2 tests, and
Pearson’s correlation were used for the analyses and the
significance level was set at P \ 0.05.
Results The overall infection rates were 31.0 % in the
BMI \25 kg/m2 group, 29.0 % in the BMI 25–30 kg/m2
group, and 24.5 % in the BMI [30 kg/m2 group
(P = 0.519). The female patients developed significantly
fewer infectious complications than the male patients (26.8
vs. 73.2 %; P \ 0.001). The incidence of death was sig-
nificantly decreased according to the BMI group (8.8 vs.
7.2 vs. 1.5 %; P \ 0.0001) and the female population had a
significantly lower mortality rate (4.1 vs. 13.4 %;
P \ 0.0001). Pearson’s correlations between the Abbrevi-
ated Injury Scale (AIS) score and the corresponding
infectious foci were not significant.
Conclusion Higher BMI seems to be protective against
polytrauma-associated death but not polytrauma-associated
infections, and female gender protects against both poly-
trauma-associated infections and death. Understanding
gender-specific immunomodulation could improve the
outcome of polytrauma patients.
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Introduction
Different results have been reported for the association
between body mass index (BMI) and polytrauma [1, 2].
BMI is an anthropometric index defining the weight-to-
height relationship, and is expressed as the weight of the
individual in kilograms divided by the square of his/her
height in meters (kg/m2). Individuals with normal weight
have BMIs between 18.5 and 24.9 kg/m2; overweight is
defined as BMI C25 kg/m2 and obesity as BMI C30 kg/
m2. BMI values are age- and sex-independent [3], and
obesity is known to be one of the most significant risk
factors for diseases such as cancer, heart disease, and
diabetes mellitus in Western-oriented countries, called the
metabolic syndrome [4]. To date, the association between
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chronic diseases and obesity seems to be clear, but the
impact of obesity on patients’ immunity in critical care
settings after polytrauma remains unclear [2, 5]. It is also a
well-known fact that overweight people have a higher
incidence in infectious viral diseases such as pandemic
influenza A (H1N1), but the question remains as to whether
it is caused by obesity itself or by its secondary effects,
such as obstructive ventilation [6]. Obesity not only hinders
nursing procedures, but also negatively affects airway
management, and makes surgical exposure more difficult
and radiographic imaging less feasible and less reliable [7].
However, one report claimed that overweight, obese, and
severely obese patients in critical care showed reduced
mortality and improved functional status after discharge
from hospital—whether it was due to the energy storage of
fatty tissue in a catabolic intensive care unit (ICU) stay
remains speculative [8]. This seems to contradict data from
population- and disease-based studies and a plethora of
data from the critical care literature [9–13]. Those studies
have shown that severely obese victims of blunt trauma
deteriorate rapidly and are less responsive to interventions.
Furthermore, obesity is recognized as an independent
predictor of mortality in such patients, who are also
reported to have an increased risk of multi-organ failure [2,
14]. BMI is reported to be a predictor of injury pattern and
a BMI [30 kg/m2 significantly predicted the development
of pulmonary problems and rib and pelvic fractures in
patients after blunt trauma [15]. On the other hand, there
might be also some protective effect of the fatty tissue by
its aromatase activity, converting the 4-androstenedione to
estradiol-17b [16]. This might lead to a partial feminization
of the obese patient and, thus, to a reduced incidence in
infectious complications. There is high evidence that
female patients are positively protected against infectious
complications [17–20]. Whether this ‘female advantage’ in
reality has an effect on the incidence of infectious com-
plications in polytrauma patients has not yet been tested.
However, the protective effect of estradiol-17b produced
by female patients and possibly obese patients is a well-
known fact [17–20]. In this study, the focus was placed on
the gender- and BMI-specific incidence of infections in
polytrauma patients.
Patients and methods
Patients and ethics
A total of 651 patients with polytrauma admitted to the
emergency room of the University Hospital Zu¨rich in the
period 1996–2008 were included in this study. The inclu-
sion criteria were an Injury Severity Score (ISS) C16
points, age C16 years, and admission within at least 24 h
of incurring polytrauma (ISS C16). The population was
subdivided into three groups (Table 1a), BMI \25 kg/m2,
BMI 25–30 kg/m2, and BMI [30 kg/m2, and males and
females. The minimal acceptable BMI was 18.5 kg/m2.
The observation period was 31 days. All patient data were
collected retrospectively. All data were retrieved from
patient records with the approval of the local institutional
review board (IRB) according to the University of Zu¨rich
IRB guidelines, as well as the World Medical Association
(WMA) Declaration of Helsinki and the study was con-
ducted according to the guidelines for good clinical prac-
tice (‘‘Retrospektive Analysen in der Chirurgischen
Intensivmedizin’’ Nr. StV 01-2008).
Diagnostic protocol
All hemodynamically stable patients admitted to the
trauma bay underwent an immediate whole-body computed
tomography (CT) scan. Hemodynamically unstable
patients underwent resuscitative procedures according to
the Advanced Trauma Life Support (ATLS) standards,
with a subsequent whole-body CT scan.
Primary care
The primary treatment of all patients admitted was
according to the ATLS guidelines and the previously
assessed trauma management protocol after appropriate
indications were identified [21, 22]. Briefly, after airway
intubation, ventilation, and cardiovascular management,
life-saving surgery was performed with decompression of
the body cavities, control of any hemorrhage, and the
identification of any contaminated tissues. The first surgical
interventions were followed by the stabilization of major
fractures and the radical debridement of necrotic tissues.
Trauma scoring systems
The ISS and the New Injury Severity Score (NISS) were
used to define the severity of the trauma based on the
Abbreviated Injury Scale (AIS) score [23–25]. The Acute
Physiology and Chronic Health Evaluation II (APACHE II)
score was used to evaluate the overall physiological
impairment of the patient [26].
Definition of infection
Infection was defined as the invasion and multiplication of
pathogenic microorganisms in a bodily part or tissue, such
as bacteria, viruses, and parasites that are not normally
present within the body, which may produce subsequent
tissue injury and progress to overt disease through a variety
of cellular or toxic mechanisms. An infection may cause no
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Table 1 Characteristics of the patient sample at admission. a Patient sample divided by BMI. b Patient sample divided by gender
Characteristics Total BMI 18.5–25 kg/m2 BMI 25–30 kg/m2 BMI [30 kg/m2 P-value
a
Patients (N) 651 378 224 49
Age (years) 42.9 ± 0.75 42.9 ± 1.0 43.4 ± 1.3 44.3 ± 2.4 0.715*
Sex male/female (N) 495/156 264/114 191/33 40/9 \0.0001
BMI (kg/m2) 24.7 ± 0.1 22.3 ± 0.1 27.0 ± 0.1 32.7 ± 0.6 \0.0001*
AIS head 3.9 ± 0.1 4.0 ± 0.1 4.0 ± 0.1 3.8 ± 0.3 0.841*
AIS face 2.1 ± 0.1 2.1 ± 0.1 2.2 ± 0.1 1.9 ± 0.3 0.568*
AIS thorax 3.2 ± 0.0 3.2 ± 0.1 3.2 ± 0.1 3.5 ± 0.2 0.131*
AIS abdomen 4.1 ± 0.1 4.1 ± 0.1 4.1 ± 0.1 4.3 ± 0.2 0.646*
AIS spine 3.1 ± 0.1 3.1 ± 0.1 3.1 ± 0.2 3.3 ± 0.3 0.825*
AIS extremities 2.7 ± 0.1 2.7 ± 0.1 2.6 ± 0.1 2.7 ± 0.1 0.876*
AIS pelvis 2.8 ± 0.1 2.8 ± 0.1 2.7 ± 0.1 2.5 ± 0.2 0.193*
AIS skin 1.7 ± 0.1 1.7 ± 0.1 1.7 ± 0.1 2.0 ± 0.3 0.569*
ISS 29.6 ± 0.5 28.9 ± 0.7 30.1 ± 1.0 32.8 ± 1.8 0.147*
NISS 40.1 ± 0.6 39.2 ± 0.8 41.0 ± 1.1 43.4 ± 2.3 0.160*
APACHE II 16.9 ± 0.4 16.9 ± 0.5 17.0 ± 0.6 15.5 ± 1.2 0.583*
Hemoglobin (g/L) 10.6 0.1 10.8 ± 0.2 10.7 ± 0.3 9.4 ± 0.5 0.056*
Base excess (mmol/L) -2.8 ± 0.4 -2.3 ± 0.6 -3.4 ± 0.6 -4.1 ± 1.6 0.276*
Lactate (mmol/L) 3.5 ± 0.3 3.5 ± 0.4 3.5 ± 0.2 3.5 ± 0.5 0.990*
pH 7.3 ± 0.0 7.2 ± 0.0 7.3 ± 0.0 7.3 ± 0.0 0.427*
Prothrombin time (%) 77.9 ± 1.0 76.1 ± 1.4 81.0 ± 1.6 76.5 ± 3.9 0.073*
Platelets (103/lL) 189.7 ± 3.9 189.8 ± 5.1 193.5 ± 6.7 171.7 ± 10.9 0.356*
Characteristics Male Female P-value
b
Patients (N) 495 156 \0.0001
Age (years) 40.0 ± 0.8 45.7 ± 1.6 \0.0001*
BMI (kg/m2) 25.3 ± 0.2 24.1 ± 0.3 \0.0001*
AIS head 3.6 ± 0.1 3.7 ± 0.1 0.352*
AIS face 2.2 ± 0.1 2.2 ± 0.1 0.254*
AIS thorax 3.2 ± 0.1 3.3 ± 0.1 0.657*
AIS abdomen 4.0 ± 0.1 4.2 ± 0.1 0.106*
AIS spine 3.1 ± 0.1 2.8 ± 0.1 0.211*
AIS extremities 2.8 ± 0.1 2.8 ± 0.1 0.739*
AIS pelvis 2.9 ± 0.1 2.7 ± 0.1 0.071*
AIS skin 1.6 ± 0.1 1.5 ± 0.1 0.486*
ISS 28.4 ± 0.5 28.3 ± 1.1 0.968*
NISS 38.1 ± 0.7 38.8 ± 1.3 0.668*
APACHE II 14.3 ± 0.4 15.5 ± 0.7 0.135*
Hemoglobin (g/L) 11.3 ± 0.2 10.1 ± 0.2 \0.0001*
Base excess (mmol/L) -2.9 ± 0.4 -2.9 ± 0.4 0.989*
Lactate (mmol/L) 3.1 ± 0.1 2.8 ± 0.2 0.372*
pH 7.3 ± 0.2 7.3 ± 0.1 0.237*
Prothrombin time (%) 78.3 ± 1.1 79.5 ± 2.1 0.605*
Platelets (103/lL) 195.1 ± 4.1 199.5 ± 8.9 0.623*
All BMI values are in kg/m2. Only 14 patients met the criterion for being underweight (BMI \ 18.5) and were excluded. Data are given as mean ± SEM
AIS Abbreviated Injury Scale, ISS Injury Severity Score, NISS New Injury Severity Score, APACHE II Acute Physiology and Chronic Health Evaluation II
* ANOVA
 v2 test
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symptoms and be subclinical, or it may cause symptoms
and be clinically apparent. Microorganisms that live natu-
rally in the body were not considered to constitute an
infection. All infections had to be proved by a positive
microbial culture.
Laboratory parameters
Lactate, pH, and hematocrit were measured at regular
intervals with a blood–gas analyzer (ABL800 Flex; Radi-
ometer Switzerland, GmbH, Thalwil, Switzerland). Plate-
lets were measured with flow cytometry (FACSCalibur;
Becton–Dickinson, Allschwil, Switzerland). The pro-
thrombin time was measured with a standard method
described previously [27].
Statistical analysis
Data are presented as the mean ± standard errors of the
means (SEM) for continuous variables and as percentages
for categorical variables. The data for the BMI groups were
compared using the Kruskal–Wallis and v2 tests for cate-
gorical data and with analysis of variance (ANOVA) for
continuous data. Pearson’s correlation was used to deter-
mine the dependency of the data sets. P \ 0.05 was to be
considered significant. The data were analyzed using the
SPSS statistical software (version 21.0; IBM, Armonk, NY,
USA).
Results
Patient sample
All BMI data given below are reported in kg/m2, but the
units are not included for simplicity of presentation. A total
of 651 patients met the inclusion criteria; 378 of them were
non-obese, with a BMI \25; 224 were overweight, with a
BMI 25–30; and 49 were obese, with a BMI [30. Of these
patients, 495 were male and 156 were female, with sig-
nificantly more men in all three groups (P \ 0.0001;
Table 1a). The overall mean BMI was 24.7 ± 0.1. The
mean age was 42.9 ± 0.75 years, and did not differ sig-
nificantly according to BMI (BMI \25, 42.9 ± 1.0 years;
BMI 25–30, 43.4 ± 1.3 years; and BMI [30,
44.3 ± 2.4 years; P = 0.715; Table 1a). The female
patients had a significantly lower BMI (25.3 ± 0.2 vs.
24.1 ± 0.3, male vs. female; P \ 0.0001). The female
sample was significantly older than the male sample
(40.0 ± 0.8 vs. 45.7 ± 1.6 years, male vs. female;
P \ 0.0001). There were no other differences found except
for significantly lower hemoglobin in the female sample on
admission (Table 1b). Only 14 patients (four males and ten
females) met the criteria for being underweight
(BMI \18.5) and were excluded from the study. All
patients admitted to the trauma bay who met the inclusion
criteria were included in the study.
Injury patterns
The analysis of the injury patterns according to the AIS
revealed no significant differences between the BMI
groups. In this patient sample, there were no differences
between the three groups in the ISS, NISS, or APACHE II
scores (Table 1a). The gender-specific analysis revealed no
significant differences in the injury pattern or physiological
parameters on admission (Table 1b).
Incidence of infection
There were no significant differences between the three
BMI groups in the incidence of infection (Table 2a).
However, the female sample revealed a significantly lower
incidence of infectious complications in all anatomical
region after polytrauma compared with the male population
(P \ 0.001) (Table 2b).
Correlation of injury pattern and infection
Pearson’s correlation revealed no significant association
between the injury pattern and the infectious focus. The
correlation coefficient was always negative or below 0.1.
There was absolutely no correlation between the severity of
an injury in an anatomical region and the incidence of
infection in that region (Table 3).
Outcomes
Patients with a higher BMI revealed a significantly lower
mortality rate (BMI \25, 8.8 %; BMI 25–30, 7.2 %; and
BMI [30, 1.5 %; P \ 0.0001) (Table 4a). The female
patients showed a significantly lower mortality compared
to the male sample (13.4 vs. 4.1 %, male vs. female;
P \ 0.0001) (Table 4b). There were no significant differ-
ences found between hospitalization, intensive care stay, or
ventilation in all BMI groups and in the male and female
samples (Table 4a, b).
Discussion
This study was designed to evaluate the impact of BMI
and gender on the development of infectious complications
in patients with polytrauma. Understanding the altered
physiology of obese patients with polytrauma can play a
pivotal role in their multidisciplinary treatment. In
576 L. Mica et al.
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Western-oriented societies, the prevalence of obesity is a
growing problem that appears to be altering current med-
ical and surgical treatment strategies [28]. Female gender
has a positive immunomodulatory effect on the develop-
ment of infectious complications after trauma [17–20].
Overweight patients have significantly more comorbidities
than normal-weight patients and face more post-traumatic
complications [29, 30]. In this study, the incidence of
infections was analyzed over a period of 31 days after
polytrauma. The ISS did not differ between the study
groups. The incidence of infectious complications also did
not differ with increasing BMI scores over the observation
period. On one hand, the production of estrogen by aro-
matase activity in adipocytes is a well-known phenomenon
[16]. The steroid pathway then shifts from the production
of 4-androstenedione and testosterone toward the
Table 2 a Patient sample divided by BMI. b Patient sample divided by gender
BMI group Infection CNS
infection
Pneumonia Abdominal
infection
Urinary tract
infection
Wound
infection
Catheter
infection
Male Female
a
18.5–25 kg/m2 31.0 % 4.1 % 17.7 % 2.4 % 4.5 % 7.1 % 6.6 % 69.8 % 30.2 %
25–30 kg/m2 29.0 % 3.5 % 15.6 % 0.4 % 3.5 % 7.1 % 4.9 % 85.3 % 14.7 %
[30 kg/m2 24.5 % 4.0 % 12.2 % 2.0 % 10.2 % 4.1 % 6.1 % 81.6 % 18.4 %
Total 29.8 % 4.0 % 16.6 % 1.7 % 4.6 % 6.9 % 6.0 % 76.0 % 24 %
P-value 0.519* 0.924* 0.438* 0.172* 0.146* 0.667* 0.563* \0.001* \0.001*
Gender Infection CNS infection Pneumonia Abdominal infection Urinary tract infection Wound infection Catheter infection
b
Male 33.1 % 5.1 % 18.2 % 2.1 % 5.8 % 10.4 % 5.8 %
Female 29.3 % 3.5 % 16.5 % 0.6 % 4.2 % 5.9 % 4.4 %
Total 29.8 % 4.0 % 16.6 % 1.7 % 4.6 % 6.9 % 6.0 %
P-value \0.001* \0.001* \0.001* \0.001* \0.001* \0.001* \0.001*
Data represent the incidence of infectious complications in patients after polytrauma over an observation period of 31 days. Data are given as
percentages of the respective groups
CNS central nervous system
* Kruskal–Wallis test within the BMI and gender groups
Table 3 Pearson’s correlation between the incidence of infectious complications and the injury severity in the corresponding anatomical region
P-value*
Pearson’s correlation
AIS head AIS face AIS thorax AIS abdomen AIS spine AIS extremities AIS pelvis AIS skin
Infection 0.476 0.588 0.351 0.345 0.966 0.734 0.775 0.079
-0.029 -0.022 -0.037 -0.038 0.002 -0.014 0.011 -0.070
CNS infection 0.742 0.829 0.374 0.196 0.400 0.208 0.787 0.950
0.013 -0.009 -0.036 -0.052 -0.034 0.050 0.011 0.003
Pneumonia 0.245 0.372 0.406 0.706 0.760 0.659 0.525 0.211
-0.046 -0.036 -0.033 0.015 -0.012 0.018 0.025 -0.050
Abdominal infection 0.662 0.702 0.964 0.445 0.041 0.446 0.255 0.911
-0.017 0.015 0.002 -0.031 0.082 0.030 -0.045 -0.004
Urinary tract infection 0.365 0.192 0.878 0.242 0.189 0.578 0.744 0.081
-0.036 0.052 -0.006 0.047 -0.053 0.022 -0.013 -0.070
Wound infection 0.986 0.533 0.210 0.605 0.830 0.163 0.955 0.311
0.001 -0.025 -0.050 0.021 0.009 -0.056 0.002 -0.041
Catheter infection 0.272 0.662 0.397 0.525 0.606 0.648 0.352 0.590
-0.044 0.017 0.034 0.025 0.021 0.018 0.037 0.022
There was a significant correlation between spinal injury severity and abdominal infection, but the correlation coefficient was very low
* ANOVA, Pearson’s correlation
AIS Abbreviated Injury Scale, CNS central nervous system
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production of estrone and estradiol-17b. Feminine steroids
are highly protective against inflammatory reactions [27].
The data presented here indicate no difference in the
incidence of infections in the overweight patients in this
study. The production of estradiol-17b produced by the
adipocytes seems not to be effective enough for the ‘fem-
inine protection’ against infectious complications. How-
ever, the feminine gender was significantly protected
against infectious complications without differences in
injury severity or pre-existing diseases reflected by the ISS
and APACHE II scores. The question as to whether the
injury pattern correlates to a specific anatomical region
seems to be negatively answered. There was no correlation
between the injured anatomical region and an infection
within that anatomical region, so the injury itself did not
constitute an infectious focus. Only spinal injuries and
abdominal infections correlated significantly, but with a
low correlation coefficient. This may suggest a random
association. On the other hand, polytrauma patients face a
catabolic state early, with consumption of the body’s energy
reserves, decreasing the functionality of the immunity sys-
tem. A slightly elevated BMI may provide enough energy in
a polytrauma situation to keep the immunity system func-
tional, which is mirrored in the better survival rate accord-
ing to the increasing BMI. Taking all the findings together,
the outcomes of the overweight patients were not better than
those of the normal-weight patients, but the mortality rate
decreased significantly in the overweight BMI group and in
the female group. It can be stated definitively that females
are protected against infectious complications in poly-
trauma conditions, whereas the overweight and obese
patients are not. Further analyses that include the assess-
ment of hormonal status and precise measurements of body
fat might be more conclusive. The knowledge of hormonal
immunomodulation could improve the outcome of severe
infections and sepsis in polytrauma patients.
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